Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice
2023 · Cell Reports Medicine · 45 citations
https://doi.org/10.1016/j.xcrm.2023.100918
L
Lili Wu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
51
Papers
4.9K
Citations
19
h-index
27
i10-index
Lili Wu is an academic researcher from Zhejiang Wanli University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Animal Virus Infections Studies. The author has an h-index of 19, co-authored 44 publications.
ORCID: 0000-0002-6749-1727Papers by this author
worksTwo noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infections
2024 · Nature Communications · 35 citations
https://doi.org/10.1038/s41467-024-48312-2
A binding-enhanced but enzymatic activity-eliminated human ACE2 efficiently neutralizes SARS-CoV-2 variants
2022 · Signal Transduction and Targeted Therapy · 14 citations
https://doi.org/10.1038/s41392-021-00821-y
A cross-section study of the relationship between lifestyles and severity of COVID-19 symptoms in people living with HIV
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-99528-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat